Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Revenue (2016 - 2025)

CorMedix's Revenue history spans 14 years, with the latest figure at $128.6 million for Q4 2025.

  • For Q4 2025, Revenue rose 312.1% year-over-year to $128.6 million; the TTM value through Dec 2025 reached $311.7 million, up 630.86%, while the annual FY2025 figure was $311.7 million, 617.03% up from the prior year.
  • Revenue for Q4 2025 was $128.6 million at CorMedix, up from $104.3 million in the prior quarter.
  • Across five years, Revenue topped out at $128.6 million in Q4 2025 and bottomed at -$9835.0 in Q1 2024.
  • The 5-year median for Revenue is $38088.0 (2021), against an average of $20.9 million.
  • The largest annual shift saw Revenue tumbled 214.93% in 2023 before it skyrocketed 606213.33% in 2025.
  • A 5-year view of Revenue shows it stood at $56396.0 in 2021, then tumbled by 47.33% to $29702.0 in 2022, then tumbled by 129.55% to -$8776.0 in 2023, then surged by 355726.32% to $31.2 million in 2024, then skyrocketed by 312.1% to $128.6 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Revenue are $128.6 million (Q4 2025), $104.3 million (Q3 2025), and $39.7 million (Q2 2025).